Canopy Growth Co. (NASDAQ:CGC - Get Free Report) was the recipient of a large decline in short interest during the month of October. As of October 31st, there was short interest totalling 8,220,000 shares, a decline of 10.9% from the October 15th total of 9,230,000 shares. Based on an average daily trading volume, of 4,600,000 shares, the short-interest ratio is currently 1.8 days. Approximately 9.8% of the company's shares are sold short.
Canopy Growth Trading Down 0.3 %
Shares of NASDAQ CGC traded down $0.01 during trading on Friday, reaching $3.73. The company had a trading volume of 4,124,734 shares, compared to its average volume of 8,645,194. The company's fifty day moving average price is $4.56 and its 200-day moving average price is $6.37. Canopy Growth has a 12 month low of $2.76 and a 12 month high of $14.92. The stock has a market cap of $392.99 million, a P/E ratio of -0.76 and a beta of 0.87. The company has a quick ratio of 1.64, a current ratio of 1.39 and a debt-to-equity ratio of 0.82.
Institutional Investors Weigh In On Canopy Growth
Institutional investors have recently made changes to their positions in the stock. B. Riley Wealth Advisors Inc. bought a new stake in shares of Canopy Growth during the 1st quarter valued at about $475,000. Murchinson Ltd. bought a new stake in shares of Canopy Growth during the 1st quarter valued at about $13,149,000. Tidal Investments LLC bought a new stake in shares of Canopy Growth during the 1st quarter valued at about $21,718,000. Virtu Financial LLC bought a new stake in shares of Canopy Growth during the 1st quarter valued at about $544,000. Finally, Baader Bank Aktiengesellschaft boosted its position in shares of Canopy Growth by 137.3% during the 2nd quarter. Baader Bank Aktiengesellschaft now owns 135,275 shares of the company's stock valued at $873,000 after purchasing an additional 78,275 shares in the last quarter. Institutional investors own 3.33% of the company's stock.
Canopy Growth Company Profile
(
Get Free Report)
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.
See Also
Before you consider Canopy Growth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.
While Canopy Growth currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
